You have 9 free searches left this month | for more free features.

177lu-dotatate

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

Recruiting
  • Neuroendocrine Tumours (NET)
  • Neuroendocrine Carcinomas (NEC)
  • Santiago De Compostela, Galicia, Spain
  • +4 more
Aug 1, 2022

Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
  • 177Lu-DOTATATE
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 19, 2023

Gastro-intestinal Neuroendocrine Tumors Trial in Brussels, Leuven (Interferon alpha-2b, 177Lu-DOTATATE)

Withdrawn
  • Gastro-intestinal Neuroendocrine Tumors
  • Interferon alpha-2b
  • 177Lu-DOTATATE
  • Brussels, Belgium
  • +1 more
Apr 4, 2016

Neuroendocrine Tumors Trial in Houston (177Lu-DOTATATE)

Unknown status
  • Neuroendocrine Tumors
  • 177Lu-DOTATATE
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Aug 3, 2015